Emotional freedom technique will be applied to menopausal women. Emotional freedom technique group, sham emotional freedom technique group and control groups each consisted of 35 menopausal women.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Determining the level of perimenopausal depression
Timeframe: The Perimenopausal Depression Scale will be administered to three groups of menopausal women on day one (first interview).
Determining the level of perimenopausal depression
Timeframe: The Perimenopausal Depression Scale will be administered to three groups of menopausal women at the last interview (after the 4th intervention at one week interval).
Determining quality of life
Timeframe: The Menopause Specific Quality of Life Scale will be administered to three groups of menopausal women on day one (first interview).
Determining quality of life
Timeframe: The Menopause Specific Quality of Life Scale will be administered to three groups of menopausal women at the last interview (after the 4th intervention at one week interval).
Assessment of menopausal symptoms
Timeframe: The Menopausal Symptoms Rating Scale will be administered to three groups of menopausal women on day one (first interview).
Assessment of menopausal symptoms
Timeframe: The Menopause Symptoms Assessment Scale will be administered to three groups of menopausal women at the last interview (after the 4th intervention at one week interval).
Determining the level of anxiety
Timeframe: The Subjective Units of Experience (SUE) scale will be administered to three groups of menopausal women on day one (first interview).
Determining the level of anxiety
Timeframe: One hour after the first interview, all menopausal women in all three groups will be administered the SUE (second measure).
Determining the level of anxiety
Timeframe: Seven days after the first interview, all menopausal women in all three groups will be administered the SUE (third measurement).
Determining the level of anxiety
Timeframe: One hour after the third measurement, all menopausal women in all three groups will be administered the SUE (fourth measurement).
Determining the level of anxiety
Timeframe: Seven days after the fourth measurement, all menopausal women in all three groups will be administered the SUE (fifth measurement).
Determining the level of anxiety
Timeframe: One hour after the fifth measurement, all menopausal women in all three groups will be administered the SUE (sixth measurement).
Determining the level of anxiety
Timeframe: Seven days after the sixth measurement, all menopausal women in all three groups will undergo the SUE (seventh measurement).
Determining the level of anxiety
Timeframe: One hour after the seventh measurement, all menopausal women in all three groups will be administered the SUE (eighth measurement).